Ngati magulu anu a triglyceride akukwera, chisamaliro chanu chaumoyo chingasankhe kuyesa ndikuchepetsani magawo anu mwa kusintha moyo wanu. Izi zikuphatikizapo kupanga zakudya zanu zathanzi, kutaya thupi, kapena kuthana ndi matenda - monga shuga osayendetsedwa - zomwe zingachititse kuti magulu anu a triglyceride akhale apamwamba kwambiri. Ngati kusinthaku sikugwira ntchito - kapena ngati triglycerides yanu ili pamwamba - wothandizira zaumoyo wanu angasankhe kuwonjezera mankhwala.
Izi ndi pamene mankhwala monga Vascepa angapangidwe kwa inu.
Vascepa (icosapent ethyl) ndi mawonekedwe a omega-3 fatty acid, eicosapentaenoic acid (EPA), ndipo amachotsedwa ndi anthu amene apezeka ndi hypertriglyceridemia , yomwe ili ndi zigawo za triglyceride zazikulu kapena zofanana ndi 500 mg / dL . Ngati mwauzidwa kuti mankhwalawa atenge, muyenera kukhalanso ndi zakudya kuti muchepetse mayendedwe anu a triglyceride. Vascepa inavomerezedwa kuti igwiritsidwe ntchito ku United States ndi Food and Drug Administration (FDA) mu July 2012.
Pali zochepa zofufuza zomwe zafufuza za chitetezo ndi mphamvu ya Vascepa pochepetsa triglycerides. Phunziro lofunika kwambiri, mayesero a MARINE, anayerekezera luso lochepetsa mphamvu ya Vascepa ku malo a anthu omwe ali ndi magulu a triglyceride pakati pa 500 ndi 2000 mg / dL pa sabata 12. Poyerekeza ndi placebo, magulu a triglyceride adatsitsidwa ndi 33% mwa iwo omwe amatenga magalamu 4 a Vascepa tsiku ndi tsiku.
Kuwonjezera apo, VLDL inachepetsedwa ndi 28.6%. LDL ndi HDL zinatsitsa pang'ono, komabe, kuchepetsa kumeneku sikunali kofunika kwambiri. Palibe kusiyana kwakukulu mu zizindikiro zofunika, shuga za magazi, ndi michere yambiri ya chiwindi zinkatchulidwa mwa anthu omwe amatenga Vascepa motsutsana ndi iwo omwe ali ndi placebo.
Kodi Vascepa Amagwira Ntchito Motani?
Vascepa amagwira ntchito pochepetsa kuchuluka kwa triglycerides yomwe imapangitsidwa m'chiwindi.
Kuonjezerapo, Vascepa imachulukitsa kuchotsedwa kwa triglycerides kuchokera ku VLDL particles omwe amazungulira m'magazi anu. Njira yeniyeni yomwe Vascepa amachitira izi sizodziwika, ngakhale pakhala pali njira zingapo zoperekedwa.
Kodi Muyenera Kutenga Mankhwalawa Motani?
Muyenera kutenga Vascepa monga momwe mwakhalira ndi wothandizira zaumoyo wanu. Mankhwala amodzi a Vascepa amakhala ndi kutenga makapisozi awiri kawiri (tsiku lonse la magalamu 4). Ma capsules ayenera kutengedwa ndi chakudya ndipo sayenera kuphwanyidwa, kutayidwa, kapena kudula pakati. Muyeneranso kutsata moyo wathanzi - monga kutenga masewera olimbitsa thupi komanso kudya zakudya zabwino - musanayambe kumwa Vascepa.
Kodi Ndizimene Ndiyenera Kuyembekezera Kodi Ndiyenera Kugwiritsa Ntchito Vascepa?
Muzofukufuku, zotsatira zoyipa zodziwika kwambiri ndizokutsekula m'mimba ndi khunyu, ngakhale kuti anthu ambiri omwe amatenga placebo adakumananso ndi zotsatira zake. Mwinanso mungathe kupwetekedwa ndi pakhosi, chifukwa zotsatirazi zinawonetsanso anthu omwe amatenga Vascepa.
Muyenera kulola wothandizira zaumoyo wanu kuti adziŵe mavuto omwe mumakumana nawo pamene mukudya Vascepa - makamaka ngati akuvutitsa kapena akusokoneza ntchito zanu za tsiku ndi tsiku.
Ndani Asamalandire Mankhwalawa?
Musagwire Vascepa ngati munayamba mwachitapo kanthu ndi Vascepa kapena mankhwala ake onse.
Chifukwa chakuti EPA yasinthidwa kuchokera ku mafuta omwe amachokera ku nsomba, Vascepa iyenera kugwiritsidwa ntchito mosamala ngati muli ndi zovuta zowonjezera nsomba kapena nsomba. Vascepa simunaphunzirepo kwa anthu omwe ali ndi nsomba kapena nkhono zosautsa.
Vascepa nayenso sanaphunzire kwambiri mwa anthu omwe ali ndi impso kapena matenda a chiwindi. Ngati muli ndi chiwindi kapena matenda a nthendayi kapena kuwonongeka, muyenera kulola wothandizira zaumoyo wanu kudziwa. Adzasankha ngati Vascepa kapena woyenera akuyang'anira matenda anu pamene muli pa mankhwala.
Chogulitsachi sichinaphunzirepo m'mayi omwe ali ndi pakati kapena omwe akuyamwitsa.
Choncho Vascepa ayenera kutengedwa ngati akufunikiradi.
Kodi Mankhwalawa Adzagwirizananso ndi Mankhwala Osokoneza Bongo Amene Ndikumatenga?
Sikuoneka kuti pali kusiyana pakati pa Vascepa ndi mankhwala ena. Ngakhale kuti Vascepa sanawoneke ndi mankhwala a antiticoagulant kapena kuti amachititsa kuti magazi awonongeke kwambiri, kafukufuku wina wasonyeza kuti kuchuluka kwa mafuta omega-3 mafuta acids kungachepetse mphamvu ya magazi anu. Choncho, ngati mutenga mankhwala amtundu uliwonse omwe amakhudza momwe magazi anu amatha kukhalira, wothandizira zaumoyo wanu adzifufuza nthawi zonse. Muyeneranso kulola wothandizira zaumoyo wanu kuti adziwe kuti mukumwa mankhwala ena, mankhwala owonjezera, kapena zogulitsa mankhwala musanayambe Vascepa.
Pansi
Kafukufuku wasonyeza kuti Vascepa angachepetse mayendedwe a triglyceride kwa anthu amene apezeka ndi ma level triglyceride kwambiri kapena kuposa 500 mg / dL. Kuwonjezera pa kutenga Vascepa, zifukwa zina zomwe zingapangitse maulendo a triglyceride - monga kudya, kuchita zolimbitsa thupi, mankhwala ena, kapena matenda ena, hypothyroidism kapena shuga - ayenera kuthandizidwa. Magulu a triglyceride omwe amatsatiridwa amasonyeza kuti amachititsa kuti matenda a mtima asapitirire komanso kutupa kwapasitiki. Vascepa sanaphunzirepo pofuna kuteteza matenda a mtima kwa nthawi yayitali kapena kupanikizika, ngakhale kuti zikuwoneka kuti pali phunziro lomwe likuyang'anitsitsa kuthekera kwa Vascepa kuteteza chochitika choyamba cha mtima kwa anthu omwe ali ndi triglycerides kwambiri.
Zotsatira:
> Ballantyne CM, Bays HE, Kastelein JJ et al. Kuchita bwino ndi chitetezo cha eicosapentaenoic acid ethyl ester (AMR101) mankhwala ochiritsira odwala omwe ali ndi triglycerdies apamwamba (kuyambira ku ANCHOR). Am J Cardiol 2012; 110: 982-992.
Bays HE, Braeckman RA, Ballantyne CM, et al. Ethanl, EPA omega-3 fatty acid, yoyera kwambiri: zotsatira pa lipoprotein particle concentration ndi kukula kwa odwala omwe ali ndi chiwerengero chachikulu cha triglyceride (kuphunzira kwa MARINE). J Clinic Lipidol 2012; 6: 565-572.
Nelson SD, Munger MA. Ethyl yosakanikirana ndi mankhwala a triglyceride. Ann Azimayi Akazi Omwe Akumayi 2013; 27: 1517-1523.
> Vascepa® (icosapent ethyl) Package Insert. Amarin Pharmaceuticals. June 2015.